机器人辅助腹腔镜子宫肌瘤剥除术临床分析  

Robotic-assisted laparoscopic hysteromyoma enucleation

作　　者：蔡圣芸[1] 吕昆明[1] 汪静文[1] 李励[1] 奚佳燕 徐明娟[1] 

机构地区：[1]解放军第二军医大学长海医院妇产科,上海200433

出　　处：《中华腔镜外科杂志（电子版）》2014年第1期14-16,共3页Chinese Journal of Laparoscopic Surgery(Electronic Edition)

摘　　要：目的探讨达芬奇机器人手术系统辅助腹腔镜子宫肌瘤剥除手术的安全性与可行性。方法回顾性总结2012年12月至2013年10月实施的16例达芬奇机器人辅助子宫肌瘤剥除手术的治疗效果。结果 16例患者手术均顺利完成,无中转开腹。手术时间(170.0±45.3)min,术中失血量(196.9±186.9)ml,术后肠蠕动恢复时间为(45.1±8.2)h,术后住院时间(4.2±1.5)d,除1例术后出现尿潴留,留置尿管3 d后恢复排尿功能外,未出现出血、感染等并发症。结论达芬奇机器人手术系统应用于子宫肌瘤剥除手术安全可行。Objective To investigate the safety and feasibility of robotic-assisted laparoscopic hysteromyoma enucleation. Methods The clinical outcomes of 16 patients with hysteromyoma undergoing robotic-assisted laparoscopic enucleation from December 2012 to October 2013 were retrospectively evaluated. Results All the operations were performed successfully.The operative time was （170.0 ±45.3）min.The estimated blood loss was （196.9 ± 186.9）ml.Time to the return of bowel function was （45.1 ± 8.2）h and postoperative hospital stay was （4.2 ± 1.5）d. There was one patient had a retention of urine at the first afternoon after operation, and recovered after 3--days-long indwelling eathete1：No bleeding, infections, or other complications were found. Conclusion Robotic-assisted laparoscopic hysteromyoma enucleation is safe and feasible.

关 键 词：子宫肌瘤 子宫肌瘤剥除术 达芬奇系统 

分 类 号：R737.33[医药卫生—肿瘤]